Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.480
+0.100 (2.96%)
Sep 12, 2025, 4:00 PM EDT - Market closed
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts that cover Perspective Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $12.9, which forecasts a 270.69% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $20.
Price Target: $12.9 (+270.69%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 23, 2025.
Analyst Ratings
The average analyst rating for Perspective Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 4 | 4 | 4 |
| Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +244.83% | Jun 23, 2025 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +216.09% | Jun 23, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +359.77% | Jun 3, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +129.89% | May 14, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $21 → $10 | Strong Buy | Maintains | $21 → $10 | +187.36% | Apr 7, 2025 |
Financial Forecast
Revenue This Year
964.41K
from 1.45M
Decreased by -33.67%
Revenue Next Year
715.41K
from 964.41K
Decreased by -25.82%
EPS This Year
-1.19
from -1.23
EPS Next Year
-1.40
from -1.19
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.6M | 1.7M | |||
| Avg | 964,410 | 715,408 | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.5% | 74.2% | |||
| Avg | -33.7% | -25.8% | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.87 | -0.87 | |||
| Avg | -1.19 | -1.40 | |||
| Low | -1.31 | -1.94 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.